Precipio Inc. (PRPO) stock rises during current market trading. Here’s to know why?

AVGR Stock

Precipio Inc. (NASDAQ: PRPO) stock gained by 22.49% in the current market trading. Precipio has created a program that aims to eliminate misdiagnosis by using the intellect, experience, and technologies gained within academic institutions by providing high-quality diagnostic information to physicians and their patients around the world, as well as proprietary goods that service laboratories […]

Kohl’s Corp. (KSS) stock declines during current market. Why is it so?

IMTE Stock

Kohl’s Corp. (NASDAQ: KSS) stock declined by 10.66% at the last check in the current market. Kohl’s is one of the most well-known omnichannel retailers. Kohl’s delivers amazing national and exclusive products at great savings for families everywhere, with over 1,100 locations in 49 states and the online comfort of Kohls.com and the Kohl’s App. […]

Medalist Diversified REIT Inc. (MDRR) stock gains during pre-market. Let’s find out why?

GMVD Stock

Medalist Diversified REIT Inc. (NASDAQ: MDRR) stock surged by 4.26% at last close while the MDRR stock price continues to rise by 0.68% in the pre-market trading session. Medalist Diversified REIT Inc. is a real estate investment trust headquartered in Virginia that focuses on acquiring, purchasing, and controlling value-add commercial real estate in the Mid-Atlantic […]

ESSA Pharma Inc. (EPIX) stock soars during pre-market. What has been happening?

ORC Stock

ESSA Pharma Inc. (NASDAQ: EPIX) stock gained by 9.68% at last close while the EPIX stock price rises by 5.73% during the pre-market trading session. ESSA is a clinical-stage pharmaceutical company specializing in the development of new and patented drugs for the care of prostate cancer patients. Recent Development ESSA Pharma revealed on May 10, […]

Why did Seelos Therapeutics Inc. (SEEL) stock price plunge in premarket?

NXTP Stock

Seelos Therapeutics, Inc. (SEEL), a clinical-stage biopharmaceutical company specializing to develop technologies and therapeutics for the treatment of central nervous system and respiratory disorders, declared the commencement of an underwritten public offering of shares of common stock. At last check, shares of Seelos Therapeutics Inc. (SEEL) were down -7.34% at $3.03. SEEL’s stock closed the […]